Latest News About Lilly Corporate Center

I don’t have live access to the latest news in this moment, but I can share what recent reporting has highlighted about Lilly Corporate Center and Lilly’s related expansions.

• The Lilly Medicine Foundry project in Lebanon, Indiana, was announced in October 2024 as a $4.5 billion investment combining research and manufacturing to accelerate drug development and clinical supply; opening is planned for late 2027. This represents a major expansion tied to Lilly’s U.S. manufacturing and R&D footprint.[1][5]

• Lilly has been pursuing a broader U.S. manufacturing expansion program, including new or expanded facilities in Indiana, North Carolina, Wisconsin, and Alabama, with a combined multi-billions-in-dollars investment footprint and thousands of jobs across sites. This includes plans to build four new sites and to grow existing campuses, reinforcing a domestic supply chain for small molecules, biologics, and injectables.[3][4][6][9]

• Specific site announcements beyond Indiana include a notable new Huntsville, Alabama facility announced in late 2025 with a multi-billion investment focused on synthetic APIs and peptide medicines, complementing Lilly’s overall manufacturing strategy in the U.S.[2][8]

If you’d like, I can pull the very latest headlines and summarize what happened most recently (e.g., this week or this month) and provide source links. I can also create a quick timeline or a chart of Lilly’s announced U.S. manufacturing investments to help visualize the scale and dates.